Quick Takeaways
- Invus Global Management, LLC filed SCHEDULE 13G/A for Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX).
- Disclosed ownership: 9.6%.
- Date of event: 30 Jun 2025.
Invus Global Management, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)
- Filing Manager
- Invus Global Management, LLC
- Reporting Manager
- Raymond Debbane
- Symbol
- BCAX
- Shares outstanding
- 54,343,427 shares
- Disclosed Ownership
- 5,216,969 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 31 Jul 2025, 14:56:34 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Invus Global Management, LLC disclosed 9.6% ownership in Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jul 2025, 14:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 8.9% | 4,861,944 | 4,861,944 | 0 | /s/ Raymond Debbane | Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 8.9% | 4,861,944 | 4,861,944 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 8.9% | 4,861,944 | 4,861,944 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 8.9% | 4,861,944 | 4,861,944 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 0.7% | 355,025 | 355,025 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 0.7% | 355,025 | 355,025 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 0.7% | 355,025 | 355,025 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 9.6% | 5,216,969 | 5,216,969 | 0 | /s/ Raymond Debbane | Raymond Debbane |